Literature DB >> 19482590

LEI/L-DNase II: interplay between caspase-dependent and independent pathways.

Alicia Torriglia1, Chloe Lepretre.   

Abstract

Caspase activation has been seen, for several years, as the biochemical marker of apoptosis. However, in 2005 the Nomenclature Committee on Cell Death (NCCD) established that the 'official' classification of cell death had to rely on morphological criteria owing to the absence of a clear-cut equivalence between structural alterations and biochemical pathways. Actually, the controlled destruction of the cell is coordinated by a proteolytic system involving caspases but also other proteases like cathepsins, calpains and serine proteases. These enzymes participate in an activation cascade that culminates in cleavage of a set of proteins resulting in disassembly of the cell. This disassembling also includes the activation of endonucleases that will destroy a potentially harmful DNA. A caspase-activated DNase performs DNA degradation in caspase-dependent apoptosis, but other endonucleases like L-DNase II or GAAD are activated in caspase-independent apoptosis, allowing the complete dismantling of the cell.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19482590     DOI: 10.2741/3572

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  3 in total

1.  Dual Detection of Nucleolytic and Proteolytic Markers of Lysosomal Cell Death: DNase II-Type Breaks and Cathepsin D.

Authors:  Candace L Minchew; Vladimir V Didenko
Journal:  Methods Mol Biol       Date:  2017

2.  DNase 2 is the main DNA-degrading enzyme of the stratum corneum.

Authors:  Heinz Fischer; Jennifer Scherz; Sandra Szabo; Michael Mildner; Charaf Benarafa; Alicia Torriglia; Erwin Tschachler; Leopold Eckhart
Journal:  PLoS One       Date:  2011-03-01       Impact factor: 3.240

3.  Caspase-1 activity affects AIM2 speck formation/stability through a negative feedback loop.

Authors:  C Juruj; V Lelogeais; R Pierini; M Perret; B F Py; Y Jamilloux; P Broz; F Ader; M Faure; T Henry
Journal:  Front Cell Infect Microbiol       Date:  2013-04-24       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.